Specifically, through single-cell spatial transcriptomic analysis, they identified a pronounced enrichment of interleukin-6 family signaling, which was functionally shown to confer tumor cell resistance to chemotherapeutic agents [24]. This evidence concerns the gene IL6 and neoplasm.